Amniotics AB (OSTO:AMNI) Short-Term Debt : kr2.58 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Amniotics AB Short-Term Debt?

Amniotics AB's Short-Term Debt for the quarter that ended in Dec. 2023 was kr2.58 Mil.

Amniotics AB's quarterly Short-Term Debt stayed the same from Jun. 2023 (kr0.00 Mil) to Sep. 2023 (kr0.00 Mil) but then increased from Sep. 2023 (kr0.00 Mil) to Dec. 2023 (kr2.58 Mil).

Amniotics AB's annual Short-Term Debt increased from Dec. 2021 (kr0.00 Mil) to Dec. 2022 (kr15.07 Mil) but then declined from Dec. 2022 (kr15.07 Mil) to Dec. 2023 (kr2.58 Mil).

Amniotics AB Short-Term Debt Historical Data

The historical data trend for Amniotics AB's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amniotics AB Short-Term Debt Chart

Amniotics AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

15.07

2.58

Amniotics AB Quarterly Data
	Dec19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Short-Term Debt	Get a 7-Day Free Trial										-	15.07	-	-	2.58

Amniotics AB Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Amniotics AB Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Amniotics AB's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Amniotics AB (OSTO:AMNI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amniotics AB (OSTO:AMNI) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

66J:Germany

Address

Scheelevagen 2, Lund, SWE, 223 63

Website

https://www.amniotics.com

Amniotics AB is a biopharma company focusing on mesenchymal stem cells from amniotic fluid. It provides a novel platform for the production of medically superior mesenchymal stem cells including ethical and medically sound bio-banking opportunities for the newborn.